BENJAMIN MARTINEZ-ANDUJO: Open Payments
NPI 1952321150 · KEENESBURG, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 19 payments from 8 companies in 2025. Trend: 2023 $528 · 2024 $527 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: Kerendia, BREZTRI, MOUNJARO, CAPLYTA, GVOKE HYPOPEN, ROTATEQ, AIRSUPRA, FARXIGA.
Industry payments across CO — which companies pay providers there.
